CAS: 1798328-24-1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | TD52 REF: IN-DA01EQFNCAS: 1798328-24-1 | 98% | A consultar | Vie 04 Abr 25 |
 | TD52 REF: TM-T35528CAS: 1798328-24-1 | 99.5% | 67,00 €~96,00 € | Vie 11 Abr 25 |
 | N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine REF: 3D-YWC32824CAS: 1798328-24-1 | Min. 95% | 331,00 €~1.307,00 € | Vie 16 May 25 |
Ref: IN-DA01EQFN
| 5mg | 149,00 € | ||
| 50mg | 463,00 € | ||
| 100mg | 556,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 4 de Abril de 2025
TD52
CAS:1798328-24-1
TD52, an Erlotinib derivative, is an oral CIP2A cancer inhibitor that disrupts Elk1's attachment to …
Fórmula:
C24H16N4
Pureza:
99.5%
Forma y color:
Liquid
Peso molecular:
360.41
Ref: TM-T35528
| 2mg | 96,00 € |
Entrega estimada en Estados Unidos, el Viernes 11 de Abril de 2025
N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine
CAS:1798328-24-1
Please enquire for more information about N2,N3-Bis(3-ethynylphenyl)quinoxaline-2,3-diamine including the price, delivery time and more detailed …
Fórmula:
C24H16N4
Pureza:
Min. 95%
Peso molecular:
360.41 g/mol
Ref: 3D-YWC32824
| 5mg | 331,00 € | ||
| 10mg | 342,00 € | ||
| 25mg | 570,00 € | ||
| 50mg | 869,00 € | ||
| 100mg | 1.307,00 € |
Entrega estimada en Estados Unidos, el Viernes 16 de Mayo de 2025
